Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease
LACTBENZ
1 other identifier
observational
10
1 country
1
Brief Summary
The investigators propose to study the transfer of benznidazole into breastmilk from the blood of lactating women who receive the drug for the treatment of Chagas disease. Breastmilk and blood samples will be obtained from these patients at given times after they take the clinically indicated medication, and the concentrations in both matrices will be compared to estimate degree of transfer, which in turn will be used to evaluate potential degree of exposure of infants breastfed by these women. This study will help clarify safety of continuing breastfeeding while receiving treatment with benznidazole for Chagas disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 1, 2012
CompletedFirst Posted
Study publicly available on registry
March 8, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedMarch 18, 2015
March 1, 2015
1.8 years
March 1, 2012
March 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Benznidazole concentration in breastmilk and in plasma
Randomly obtained breastmilk samples will be obtained to both evaluate the breastmilk / plasma concentration ratio of the drug, and to develop a population pharmacokinetics model of drug trasfer into breastmilk, if possible. Breastmilk concentrations will be used to calculate potential infant exposure through breastmilk to the medication (benznidazole) taken by the mother
at randomly selected time points during the 30 days of treatment
Secondary Outcomes (1)
incidence of adverse drug reactions in women treated with benznidazole during lactation
throughout the 30 days of treatment
Study Arms (1)
Lactating Women with Chagas disease
Women with Chagas disease who fulfill clinical criteria for treatment with benznidazole, and who are also lactating
Eligibility Criteria
population of young women with Chagas disease referred to our center for evaluation and treatment
You may qualify if:
- Lactating women with Chagas disease, not treated before
- Use of contraception
You may not qualify if:
- History of allergy to benznidazole or its excipients
- Pregnancy
- Significant heart involvement (due to Chagas disease)
- Significant systemic diseases that could affect the interpretation of the results in the opinion of the principal investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parasitology and Chagas Service, Buenos Aires Children´s Hospital Ricardo Gutierrez
Buenos Aires, Buenos Aires, 1425, Argentina
Related Publications (1)
Garcia-Bournissen F, Moroni S, Marson ME, Moscatelli G, Mastrantonio G, Bisio M, Cornou L, Ballering G, Altcheh J. Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease. Arch Dis Child. 2015 Jan;100(1):90-4. doi: 10.1136/archdischild-2014-306358. Epub 2014 Sep 10.
PMID: 25210104DERIVED
Biospecimen
breastmilk; plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Facundo Garcia Bournissen, MD PhD
Buenos Aires Children´s Hospital Ricardo Gutierrez ; CONICET
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Researcher
Study Record Dates
First Submitted
March 1, 2012
First Posted
March 8, 2012
Study Start
August 1, 2011
Primary Completion
June 1, 2013
Study Completion
December 1, 2013
Last Updated
March 18, 2015
Record last verified: 2015-03